Join us for New Technologies, New Vaccines

Spring, 2018




Infectious Diseases remain one of the leading causes of death and disability worldwide. Despite remarkable advances made in vaccine development in the 20th century, the ease of world travel and increased global interdependence have added complexity to fight against these infectious diseases. With an aim to provide a forum for discussing the challenges faced in the vaccine development, Fraunhofer Center for Molecular Biotechnology in cooperation with International Alliance for Biological Standardization (IABS), started the series in 2006 named “New Technologies, New Vaccines”.

The upcoming conference will commence with a keynote address by Dr. Gregory Poland of the Mayo clinic followed by sessions focusing on how systems biology is impacting vaccine development. Additional topics will include human immunogenomics, challenges faced in vaccine candidate identification and antigen expression, formulations for enhanced potency, stability and delivery and the use of alternative approaches for conducting safety and efficacy evaluations. The conference will conclude with presentations on emerging and re-emerging infections and how to guide future interventions.

The conference brings together researchers, scientists, academicians, regulatory and industry professionals from the vaccine community to discuss the most recent topics in vaccine development. The meeting will focus on the emerging and re-emerging infectious diseases, and the challenges faced in vaccine development.


  • Dr. Fred Cassels, NIH
  • Dr. Arifa Khan, FDA
  • Dr. William Egan, GSK
  • Dr. Tudor Arvinte, Therapeomic
  • Dr. Pirouz Daftarian, University of Miami, School of Medicine
  • Dr. Manon Cox, Protein Sciences
  • Dr. Vidadi Yusibov, Fraunhofer USA Center for Molecular Biotechnology
  • Dr. Jerzy Karczewski, Fraunhofer USA Center for Molecular Biotechnology
  • Ms. Jessica Humphreys, IITRI
  • Dr. Kathryn Zoon, NIAID
  • Dr. Paula Bryant, NIH/NIAID
  • Dr. Amin Khan, Novartis
  • Dr. Anthony Gilbert, RetroScreen
  • Dr. Murali Bilikallahalli, MedImmune


  • Emerging and Re-emerging Infectious Diseases
  • Mosquito Transmitted Infectious Diseases
  • Antibody Vaccines
  • Systems Biology Approach to Vaccines
  • Candidate Identification
  • Ex vivo Systems
  • Potency Assays
  • Novel Vaccines and Technologies
  • Formulation and Delivery
  • Adjuvants
  • Regulatory Issues


For more information, please contact us.